Staging system, response evaluation criteria anticipate survival in retinoblastoma patients

A proposed staging system and response evaluation criteria helped to predict event-free-survival and overall survival at baseline and after neoadjuvant chemotherapy in advanced retinoblastoma.The study included 28 patients with stage 3 retinoblastoma who underwent MRI at baseline and after three rounds of chemotherapy preceding enucleation.

Full Story →